BlackRock Fund Advisors - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 151 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$48,475,000
+40.8%
1,447,002
+11.9%
0.01%
+28.6%
Q3 2016$34,423,000
+29.9%
1,293,604
+7.6%
0.01%
+16.7%
Q2 2016$26,503,000
-23.8%
1,201,932
+1.5%
0.01%
-25.0%
Q1 2016$34,774,000
-8.4%
1,184,007
+2.9%
0.01%
-11.1%
Q4 2015$37,981,000
-8.9%
1,150,230
-0.3%
0.01%
-18.2%
Q3 2015$41,711,000
+40.4%
1,154,139
+74.8%
0.01%
+57.1%
Q2 2015$29,700,000
+84.2%
660,148
+25.4%
0.01%
+75.0%
Q1 2015$16,125,000
-37.4%
526,625
+4.0%
0.00%
-33.3%
Q4 2014$25,758,000
+161.2%
506,542
+103.2%
0.01%
+100.0%
Q3 2014$9,863,000
-10.1%
249,249
-2.1%
0.00%0.0%
Q2 2014$10,970,000
+167.3%
254,706
+148.2%
0.00%
+200.0%
Q1 2014$4,104,000
+50.8%
102,624
+2.9%
0.00%0.0%
Q4 2013$2,722,000
+13.9%
99,780
-4.3%
0.00%0.0%
Q3 2013$2,389,000
+46.8%
104,228
+13.5%
0.00%0.0%
Q2 2013$1,627,00091,8440.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 858,811$36,156,00010.56%
Fairmount Funds Management LLC 150,433$6,333,0002.26%
ARMISTICE CAPITAL, LLC 1,356,000$57,088,0001.94%
FARALLON CAPITAL MANAGEMENT LLC 1,775,000$74,728,0000.45%
Virtus ETF Advisers LLC 14,321$603,0000.25%
Granahan Investment Management 231,071$9,728,0000.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 248,320$10,454,0000.09%
ACADIAN ASSET MANAGEMENT LLC 467,514$19,684,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 126$5,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 12,854$541,0000.07%
View complete list of ENANTA PHARMACEUTICALS INC shareholders